scispace - formally typeset
D

Diederick E. Grobbee

Researcher at Utrecht University

Publications -  1108
Citations -  136069

Diederick E. Grobbee is an academic researcher from Utrecht University. The author has contributed to research in topics: Population & Risk factor. The author has an hindex of 155, co-authored 1051 publications receiving 122748 citations. Previous affiliations of Diederick E. Grobbee include National Heart Foundation of Australia & Radboud University Nijmegen Medical Centre.

Papers
More filters
Journal ArticleDOI

Prospect-EPIC Utrecht: Study design and characteristics of the cohort population

TL;DR: Based on the Prospect-EPIC population, this manuscript intends to conduct prospective total cohort, nested case–control or case–cohort studies, in order to investigate relations between consumption of certain food groups or nutrients and chronic diseases, including hormone dependant cancers.
Journal ArticleDOI

Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels

TL;DR: This study investigated the optimal analysing strategy for bleeding data by using the association of residual clotting factor level and number of joint bleeds in moderate and mild patients treated on demand as example, and found Multivariate regression analysis using negative binomial distribution provided the optimum data analytical strategy.
Journal ArticleDOI

T axis as an indicator of risk of cardiac events in elderly people

TL;DR: The T axis is a strong and independent risk indicator of fatal and non-fatal cardiac events in the elderly, and the risk associated with an abnormal T axis was higher than those for any other cardiovascular risk factor.
Journal ArticleDOI

Sodium and potassium intake and risk of cardiovascular events and all-cause mortality : the Rotterdam Study

TL;DR: There was no consistent association of urinary sodium, potassium, or sodium/potassium ratio with CVD and all-cause mortality over the range of intakes observed in this population, and the effect of sodium and potassium intake on CVD morbidity and mortality in Western societies remains to be established.
Journal ArticleDOI

Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen.

TL;DR: High‐dose prophylaxis significantly increases treatment costs and reduces joint bleeds over a period of 3 years, but only slightly reduces arthropathy after 17’years of follow‐up, suggesting that, compared with intermediate‐doseProphylactic regimens, high‐dose Prophylactive regimens significantly increases Treatment costs and joint bleeding over aperiod of 3 years, butonly slightly reducesArthropathy.